Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1996
12/24/1996US5587367 Pharmaceutical or cosmetic composition containing a combination of a retinoid and a sterol
12/24/1996US5587358 Potentiators of antimicrobial activity
12/24/1996US5587302 T cell growth factor
12/24/1996US5587161 Prodrugs for antibody directed enzyme prodrug therapy
12/24/1996CA2176998A1 Novel 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same
12/24/1996CA2020752C Treatment of bone disorders
12/23/1996CA2179679A1 Substituted benzothiazine derivative
12/23/1996CA2179105A1 Antioxidant grafted polysaccharides and their uses
12/20/1996CA2179426A1 Use of ligands specific to rxr receptors
12/19/1996WO1996041191A1 Methods and uses for apoptin
12/19/1996WO1996040948A2 RESISTANCE TO VIRUSES AND VIROIDS IN TRANSGENIC PLANT AND ANIMAL HOSTS EXPRESSING dsRNA-BINDING PROTEIN
12/19/1996WO1996040923A1 Macrophage derived chemokine and chemokine analogs
12/19/1996WO1996040911A1 Modified steroid hormones for gene therapy and methods for their use
12/19/1996WO1996040909A1 Bone stimulating factor
12/19/1996WO1996040908A1 OLIGONUCLEOTIDES SPECIFIC FOR CYTOKINE SIGNAL TRANSDUCER gp130 mRNA
12/19/1996WO1996040894A1 Treatment of insulin resistance
12/19/1996WO1996040868A1 Essential oligonucleotides of vertebrate telomerase
12/19/1996WO1996040784A2 Method of solubilizing, purifying, and refolding protein
12/19/1996WO1996040777A2 Synthetic peptides and pharmaceutical compositions comprising them
12/19/1996WO1996040775A1 Method for the treatment of corticosteroid induced osteopenia
12/19/1996WO1996040771A1 SINGLE CHAIN ANALOGS OF THE TGF-β SUPERFAMILY (MORPHONS)
12/19/1996WO1996040762A1 Monocyte chemotactic protein-4
12/19/1996WO1996040748A1 Peptidyl heterocycles useful in the treatment of thrombin related disorders
12/19/1996WO1996040747A1 Urokinase receptor ligands
12/19/1996WO1996040745A2 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
12/19/1996WO1996040737A1 Reversible cysteine protease inhibitors
12/19/1996WO1996040736A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding
12/19/1996WO1996040728A2 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds
12/19/1996WO1996040707A1 Water-soluble adenosine kinase inhibitors
12/19/1996WO1996040706A1 Orally active adenosine kinase inhibitors
12/19/1996WO1996040705A1 C-4' modified adenosine kinase inhibitors
12/19/1996WO1996040686A1 Heterocyclic substituted cyclopentane compounds
12/19/1996WO1996040681A1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
12/19/1996WO1996040679A1 Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
12/19/1996WO1996040672A1 Combinatorial libraries having aminodiol monomer subunits
12/19/1996WO1996040669A1 Retinoids and methods of use of same
12/19/1996WO1996040659A1 N-hydroxyureas as antiinflammatory agents
12/19/1996WO1996040651A1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
12/19/1996WO1996040650A1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
12/19/1996WO1996040648A1 Quinazolines and pharmaceutical compositions
12/19/1996WO1996040647A1 α-(1,3-DICARBONYLENOL ETHER) METHYL KETONES AS CYSTEINE PROTEASE INHIBITORS
12/19/1996WO1996040646A1 Dihydrophthalazine antagonists of excitatory amino acid receptors
12/19/1996WO1996040645A1 2-substituted benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
12/19/1996WO1996040644A1 2-substituted benzimidazole derivatives as smooth muscle cell proliferation inhibitors
12/19/1996WO1996040638A1 Heteroaryl diol acids as leukotriene antagonists
12/19/1996WO1996040636A1 Catechol diethers derivatives useful as pharmaceutical agents
12/19/1996WO1996040633A1 Small molecule inhibitors of rotamase enzyme activity
12/19/1996WO1996040293A1 Structurally determined metallo-constructs and applications
12/19/1996WO1996040272A1 Aav transduction of myoblasts
12/19/1996WO1996040267A1 The regulation of systemic immune responses utilizing cytokines and antigens
12/19/1996WO1996040258A2 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
12/19/1996WO1996040257A1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
12/19/1996WO1996040231A1 Method for obtaining receptor agonist antibodies
12/19/1996WO1996040224A1 Regulation of cytokine synthesis and release
12/19/1996WO1996040223A1 Oxidant scavengers
12/19/1996WO1996040218A1 Methods for increasing hematopoietic cells
12/19/1996WO1996040217A1 Thrombopoietin compositions
12/19/1996WO1996040205A1 Metabolic effects of certain glutathione analogs
12/19/1996WO1996040193A1 CYCLIC ANALOGS OF PTH AND PTHrP
12/19/1996WO1996040186A1 Relaxin-like factor and methods and uses thereof
12/19/1996WO1996040184A1 New cryptophycins from synthesis
12/19/1996WO1996040179A1 Method of improving animal health
12/19/1996WO1996040174A1 Supplemented and unsupplemented tissue sealants, methods of their production and use
12/19/1996WO1996040168A2 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device
12/19/1996WO1996040160A1 Use of pseudopterosins for promoting wound healing
12/19/1996WO1996040151A1 Use of squalamine for the manufacture of a medicament for inhibiting nhe
12/19/1996WO1996040149A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
12/19/1996WO1996040148A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
12/19/1996WO1996040147A1 Use of debromohymenialdisine and related compounds for treating osteoarthritis
12/19/1996WO1996040143A1 Imidazole compounds
12/19/1996WO1996040140A1 Inhibitors of rotamase enzyme activity
12/19/1996WO1996040137A1 METHODS OF MODULATING NF-kB TRANSCRIPTION FACTOR
12/19/1996WO1996040130A1 Methods of inducing bef-1 transcription factor
12/19/1996WO1996040116A1 Indolinone compounds for the treatment of disease
12/19/1996WO1996040110A1 Novel benzopyran compounds and methods for their use
12/19/1996WO1996040108A1 Multidentate metal complexes and methods of making and using thereof
12/19/1996WO1996040103A1 Treatment of a trabecular meshwork whose cells are subject ot inhibition of cell division with non-steroidal anti-inflammatory drugs
12/19/1996WO1996040102A1 Non-steroidal anti-inflammatory drugs for the cyto-protection of the trabecular meshwork
12/19/1996WO1996040097A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders
12/19/1996WO1996040094A1 Use of selegiline to treat hearing loss in mammals
12/19/1996WO1996040090A1 Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors
12/19/1996WO1996040040A2 Thrombin receptor homolog
12/19/1996WO1996040039A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
12/19/1996WO1996039996A1 Method for regulating metabolism with dopamine beta hydroxylase inhibitors
12/19/1996WO1996039978A1 Therapeutic use of acetazolamide for the treatment of brain edema
12/19/1996WO1996039869A1 Health food product
12/19/1996WO1996039838A1 Methods of inhibiting bacterial sialidase
12/19/1996WO1996039833A1 Modulation of calcium channels
12/19/1996WO1996036222A3 Improved method for controlling ectoparasites
12/19/1996CA2247984A1 Orally active adenosine kinase inhibitors
12/19/1996CA2247983A1 Water-soluble adenosine kinase inhibitors
12/19/1996CA2224222A1 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
12/19/1996CA2224174A1 Method for obtaining receptor agonist antibodies
12/19/1996CA2224115A1 Multidentate metal complexes and methods of making and using thereof
12/19/1996CA2224113A1 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
12/19/1996CA2224110A1 Peptidyl heterocycles useful in the treatment of thrombin related disorders
12/19/1996CA2224100A1 Novel benzopyran compounds and methods for their use
12/19/1996CA2224099A1 Monocyte chemotactic protein-4
12/19/1996CA2224097A1 The regulation of systemic immune responses utilizing cytokines and antigens
12/19/1996CA2224079A1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
1 ... 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 ... 1564